The next steps for genomic medicine: Challenges and opportunities for the:developing world

Nature Reviews Genetics

Volumn 9, Issue , 2008, Pages S23-S27

  Hardy, Billie Jo ^a   Séguin, Béatrice ^a   Goodsaid, Federico ^b   Jimenez Sanchez, Gerardo ^c   Singer, Peter A ^a,d   Daar, Abdallah S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c Gerardo Jimenez Sanchez is at the National Institute of Genomic Medicine   (United States)

^d R Samuel McLaughlin Centre for Molecular Medicine   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEVELOPING COUNTRY; GENETIC VARIABILITY; GENOMIC MEDICINE; GENOMICS; HUMAN; HUMAN GENOME PROJECT; INDIA; MEXICO; PRIORITY JOURNAL; REVIEW; SOUTH AFRICA; THAILAND;

DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; GENOMICS; HUMANS; PHARMACOGENETICS;

HARNESS;

EID: 52149090094     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg2444     Document Type: Article

References (37)

1. Cohen, R.: The world is upside down. New York Times [online], (2008).
2. Frew, S. E.:: India’s health biotech sector at a crossroads. Nature Biotechnol. 25, 403-417 (2007).
3. Frew, S. E.:: Chinese health biotech and the billion-patient market. Nature Biotechnol. 26, 37 53 (2008).
4. Rezaie, R.: Brazilian health biotech — fostering crosstalk between public and private sectors. Nature Biotechnol. 26, 627-644 (2008).
5. Banji Oyelaran-Oyeyinka.: Don’t make a fetish out of Rand D spending. Sci Dev.net [online], (2006).
6. Goldsbrough, D., Adovor, E. and Elberger, D.: What Has Happened to Health Spending and Fiscal Flexibility in Low Income Countries with IMF Programs? Center for Global Development [online], < http://www.cgdev.org/ doc/IMF/Health%20Spending.pdf> (2007).
7. Organisation for Economic Co-operation and Development. How does the United States Compare? OECD Health Data 2008 [online], < http://www.oecd. org/dataoecd/46/2/38980580.pdf> (2008).
8. Decisions of the Executive Council. Eighth Ordinary Session 16-21 January 2006, Khartoum. African Union [online], < http://www.africa-union.org/root/au/ Documents/Decisions/com/AU6th ord Council Decisions Jan2006 Khartoum.pdf > (2006).
9. Juma, C., Serageldin, I.: Freedom to Innovate: Biotechnology in Africa’s Development Report of the High-Level African Panel on Modern Biotechnology. African Ministerial Council on Science and Technology [online], < http://www.nepadst.org/doclibrary/pdfs/ biotech africarep 2007.pdf> (2007).
10. Séguin, B., Hardy, B., Singer, P A. and Daar, A. S.: Genomics, public health, and developing countries: the case of the Mexican National Institute of Genomic Medicine (INMEGEN). Nature Rev. Genet. 9 (Suppl), S5-S9 (2008).
11. Hardy, B., Séguin, B, Singer, P. A., Mukerji, M., Brahmachari, S. K. and Daar, A. S.: From diversity to delivery: the case of the Indian Genome Variation initiative. Nature Rev. Genet. 9 (Suppl), S9-S14 (2008).
12. Hardy, B., Séguin, B, Ramesar, R., Singer, P A. and Daar, A. S.: South Africa: from species cradle to genomic application. Nature Rev. Genet. 9 (Suppl), S19-S23 (2008).
13. Séguin, B., Hardy, B., Singer, P. A. and Daar, A. S.: Universal health care, genomic medicine and Thailand: investing in today and tomorrow. Nature Rev. Genet. 9 (Suppl), S14-S19 (2008).
14. Jimenez-Sanchez, G., Silva-Zolezzi, I., Hidalgo-Miranda, A. and March, S.: Genomic medicine in Mexico: initial steps and the road ahead. Genome Res. 18, 1191-1198 (2008).
15. Sirugo, G.: A national DNA bank in The Gambia, West Africa, and genomic research in developing countries. Nature Genet. 36, 785-786 (2004).
16. Sgaier, S. K.: Public health. Biobanks in developing countries: needs and feasibility. Science 318, 1074-1075 (2007).
17. Matimba, A.: Establishment of a biobank and pharmacogenetics database of African populations. Eur. J. Hum. Genet. 16, 780-783 (2008).
18. Ohnishi, Y. and Nakamura, Y.: BioBank Japan project. Nippon Rinsho 63 (Suppl 12), 35-41 (2005).
19. Palmer, L. J.: UK Biobank: bank on it. Lancet 369, 1980-1982 (2007).
20. Normile, D.: Genetic diversity. Consortium hopes to map human history in Asia. Science 306, 1667 (2004). [Editorial], Asia on the rise. Nature 447, 885 (2007).
21. Osama, A.: Opportunities and challenges in South-South collaboration. SciDev.net [online], < http://www scidev.net/en/science-and-innovation-policy/south-south-cooperation/policy-briefs/opportunities-and-challenges-in-south-south-collab.html> (2008).
22. Kelso, J.: eVOC: a controlled vocabulary for unifying gene expression data. Genome Res. 13, 1222-1230 (2003).
23. Daar, A. S.: The future of TDR: it needs to find its place in a changed global health landscape. PLoS Negl. Trop. Dis. (in the press).
24. Indian Genome Variation Consortium. Genetic landscape of the people of India: a canvas for disease gene exploration. J. Genet. 87, 3-20 (2008).
25. Höhler, T.: Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. Lancet 360, 991-995 (2002).
26. India, China to step up cooperation in traditional medicine. The Economic Times, India [online], < http://economictimes.indiatimes.com/ News/News By Industry/Healthcare Biotech/ Healthcare/India China to step up cooperation in traditional medicine/rssarticleshow/3210228.cms> (2008).
27. Jayaraman, K. S.: Database targets Parsi genes.Nature 446, 475 (2007).
28. International HapMap Consortium. A haplotype map of the human genome. Nature 437, 1299-1320 (2005).
29. The International HapMap Consortium. The International HapMap Project. Nature 426, 789-796 (2003).
30. Caulfield, T.: Research ethics recommendations for whole-genome research: consensus statement. PLoSBiol. 6, e73 (2008).
31. Séguin, B., Hardy, B. J., Singer, P. A. and Daar, A. S.: Genomic medicine and developing countries: creating a room of their own. Nature Rev. Genet. 9, 487-493 (2008).
32. Knoppers, B. M., Fortier, I., Legault, D. and Burton, P.: The Public Population Project in Genomics (P3G): a proof of concept? Eur. J. Hum. Genet. 16, 664-665 (2008).
33. Ginsburg, G. S.: Genomic medicine: ‘grand challenges’ in the translation of genomics to human health. Eur.J. Hum. Genet. 16, 873-874 (2008).
34. European Science Foundation. Populations surveys and biobanking: ESF science policy briefing 32 [online],< http://www.esf.org/publications.html >(2008).
35. Goodsaid, F. and Frueh, F. W.: Implementing the U.S.FDA guidance on pharmacogenomic data submissions. Environ. Mol. Mutagen. 48, 354-358 (2007).
36. International Conference on Harmonisation. ICH Harmonised Tripartite Guideline Definitions For Genomic Biomarkers, Pharmacogenomics, Pharmacogenetics, Genomic Data And Sample Coding Categories E15. [online], < http://www.ich.org/LOB/ mediaZMEDlA3383.pdf> (2007).
37. Masum, H., Daar, A. D., Al-Bader, S., Shah, R. and Singer, P. A.: Accelerating health product innovation in sub-Saharan Africa. Innovations: Technology, Governance, Globalization 2, 129-149 (2007).